Professional Documents
Culture Documents
Myasthenia gravis
A neuromuscular disorder,
Characterized
1) abnormal fatigability of voluntary
muscle on repetitive activity, and recover by
rest.
2) electrophysiologically decremental
response to repetitive stimulation by singlefiber electromyography.
Myasthenia gravis
3) improve by administration of
anticholinesterase drugs.
4) association with abnormality of thymus.
5) presence of circulating antibody to AChRs
and complement-mediated damage to
receptor.
Clinical picture
Involvement of various voluntary muscle
group.
Abnormal fatigability on repetitive activity
with improvement after rest.
Progressive worsening symptoms through
the day from morning to evening.
Ocular symptoms as diplopia and ptosis,
Weakness and fatigue transiently.
Clinical picture
Bulbar innervated musculature is affected
dysphagia, dysarthria, difficult in
mastication, failure of respiratory muscle.
Most serious symptoms are ventilatory
failure.
In women the symptoms may affected by
pregnancy, menses and stress.
Electrophysiology
Single fiber electromyography.
Record the jitter phenomenon.
Jitter is variable temporal separation of the
response of individual muscle fibers of the
same motor unit during activation.
Abnormally variable separation may found
more than 80% patients with myasthenia
gravis.
Pharmacologic treatment
Loewi 1932 noted acetylcholine is
neuromuscular transmission in cardiac muscle, Sir
Henry Dale 1935 noted acetylcholine is
liberated at motor nerve ending in voluntary
striated muscle1936 Nobel prize.
Propagation of action potential down a motor
nerve fiber, release acetylcholine from synaptic
vesicles, depolarization muscle.
Pharmacologic treatment
Only a small fraction of the 30-40 million
receptors per neuromuscular junction are
activated normally in response to a nerve
impulse.
The receptors excess provide large safety
ensure the repetitively neuromuscular
transmission.
Pharmacologic treatment
Anticholinesterasephysostigmine,
neostogmine, pyridostigmine block the
cholinesterase inactivation of acetylcholine,
Tensilon edrophonium chloride test
rapid action and rapid subsidence, a basic
diagnostic test.
Pathogenesis and
immunobiology
Simpson (1960) Autoimmune origin.
Almon (1974) Demonstrate circulation
antibodies to AChR site of neuromuscular
junction.
Pathogenesis and
immunobiology
Three possible mechanism
1)Accelerating the degradation of
anticholinesterase receptor through the
cross-linking phenomenon.
2)Direct blocking receptor site.
3)Actual degradation the receptor site by
complement activation.
Pathogenesis and
immunobiology
Elevated antibody level are found in 90%
patient and roughly correlated with clinical
severity.
Immunosuppressive agents as azathioprine,
corticosteroid, cyclosporine may have
benefit effect.
Pathology
Thymoma is present in 10-15% patient with
myasthenia gravis.
Normal 10-25%.
Other is thymic hyperplasia.
Thymectomy
Von Haberer 1917 transcervical
thymectomy because of thymic hyperplasia
often found in thyrotoxicosis.
Blablock 1936 upper sternotomy incision
and introduced neostigmine the operation is
success.
Thymectomy
Carlens (1968), Crile (1965), Akakura
(1965) re-describe the old technique of
transcervical thymectomy.
Papatestas (1987) perform more than
700 transcervical thymectomy.
Incomplete thymectomy is the most
important problem.
Thymectomy
Advantage of transcervical incision
incision only involve soft tissue, rarely enter
the pleural space, well tolerated by patients.
Cooper (1988) add self-retaining retractor
to aid in transcervical exposure and able to
extent transternal resection.
Type of surgical exposure is most important
determinant of the extent of resection.
Thymoma
10-15% patient with MG has thymoma.
30-50% thymoma are associated with MG.
Classifications
Result
Adult patient without thymoma undergoing
thymectomy has higher incidence of
complete remission.
Complete remove all thymic tissue fom
mediastium and lower neck from standard
transternal incision is required in surgical
treatment of myasthenia gravis.